1 reports of this reaction
2.2% of all ASPIRIN, CAFFEINE reports
#9 most reported adverse reaction
CEREBELLAR ATROPHY is the #9 most commonly reported adverse reaction for ASPIRIN, CAFFEINE, manufactured by CVS Pharmacy. There are 1 FDA adverse event reports linking ASPIRIN, CAFFEINE to CEREBELLAR ATROPHY. This represents approximately 2.2% of all 45 adverse event reports for this drug.
Patients taking ASPIRIN, CAFFEINE who experience cerebellar atrophy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CEREBELLAR ATROPHY is a less commonly reported adverse event for ASPIRIN, CAFFEINE, but still significant enough to appear in the safety profile.
In addition to cerebellar atrophy, the following adverse reactions have been reported for ASPIRIN, CAFFEINE:
CEREBELLAR ATROPHY has been reported as an adverse event in 1 FDA reports for ASPIRIN, CAFFEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CEREBELLAR ATROPHY accounts for approximately 2.2% of all adverse event reports for ASPIRIN, CAFFEINE, making it a notable side effect.
If you experience cerebellar atrophy while taking ASPIRIN, CAFFEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.